Efficacy of switches within the class of IL-17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP).

Tichy, Martin; Kojanova, Martina; Velackova, Barbora; Dolezal, Tomas; Gkalpakiotis, Spyridon; Cetkovska, Petra

Tichy, Martin; Kojanova, Martina; Velackova, Barbora; Dolezal, Tomas; Gkalpakiotis, Spyridon; Cetkovska, Petra.

Afiliação

Tichy M; Department of Dermatology and Venereology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic.
Kojanova M; Department of Dermatovenereology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
Velackova B; Value Outcomes, Prague, Czech Republic.
Dolezal T; Value Outcomes, Prague, Czech Republic.
Gkalpakiotis S; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
Cetkovska P; Department of Dermatovenereology, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic.

Dermatol Ther ; 35(10): e15772, 2022 10.

Article em En | MEDLINE | ID: mdl-36065488

Assuntos

Interleucina-17; Psoríase; Anticorpos Monoclonais/uso terapêutico; Terapia Biológica; Citocinas; República Tcheca; Humanos; Psoríase/induzido quimicamente; Psoríase/tratamento farmacológico; Sistema de Registros; Índice de Gravidade de Doença; Resultado do Tratamento

Palavras-chave

brobalumab; interleukin 17; intra-class switching; ixekizumab; secukinumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Interleucina-17 Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Dermatol Ther Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: República Tcheca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google